Porcilis Glässer vet.
Active substance
ATC code
Species
Pigs and sows.
Indications
Pigs:
Active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by G. parasuis serotype 5.
Onset of immunity: 2 weeks after completion of vaccination.
Duration of immunity: 14 weeks after completion of vaccination.
Sows:
For passive immunisation of the progeny of vaccinated sows and gilts to reduce infection, mortality, clinical signs and typical lesions of Glässer disease caused by G. parasuis serotype 5 and to reduce clinical signs and mortality caused by G. parasuis serotype 4.
Onset of immunity: After birth and sufficient uptake of colostrum.
Duration of immunity: 4 weeks of age against serotype 4 and at 6 weeks of age against serotype 5.
Dose to be administered and administration route
Intramuscular use.
Allow vaccine to reach ambient temperature. Shake well before use.
Administer 2 ml (one dose) of the vaccine intramuscularly in the neck.
Vaccination scheme pigs:
Vaccinate pigs of at least five weeks of age twice with an interval of two weeks.
Vaccination scheme sows:
Vaccinate sows at 6 to 8 weeks before expected time of farrowing twice with an interval of four weeks.
Revaccination scheme sows:
For sows vaccinated during the previous pregnancy, a single revaccination at 4 to 2 weeks before farrowing is recommended.
Adverse reactions
Pigs:
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature1 , Discomfort2, Decreased activity2, Depression2, Injection site swelling3, Injection site reddening3 |
|
Common (1 to 10 animals / 100 animals treated): |
Vomiting2 |
|
Very rare (<1 animal / 10.000 animals treated, including isolated reports): |
Anaphylactic-type reaction3 |
Sows:
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature1, Lying down2, Reduced food intake2, Decreased drinking2, Injection site swelling3 Injection site reddening3, Injection site warmth3, Injection site pain3 |
|
Common (1 to 10 animals / 100 animals treated): |
General illness2 |
1 Mean 0.9 °C, with individual animals displaying a temperature increase of above 2 °C. 2 May be observed 1 to 2 days after vaccination. All animals return to normal within 1 to 3 days after vaccination.
3 Mostly non-painful swellings < 10 cm in diameter. In some cases, swelling may be warm, red, and painful > 10 cm in diameter. These reactions disappear or clearly diminish 14 days after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
TRUSTED SOURCE
